FDA Inspection 761210 — Amplivox Ltd

Amplivox Ltd — FEI 3003138182

The FDA completed an inspection of Amplivox Ltd on December 15, 2011 in Oxford. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 11 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
December 15, 2011
Fiscal Year
2012
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Oxford (United Kingdom)

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1471521 CFR 820.30(d)Design output - Lack of or inadequate procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
265021 CFR 820.30(f)Design verification - Lack of or inadequate procedures
310121 CFR 820.30(g)Design validation- Lack of or inadequate procedures
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
323621 CFR 820.72(b)Calibration procedures - content
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation